Deutsche Bank’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-51
Closed -$299 3727
2023
Q4
$299 Hold
51
﹤0.01% 3618
2023
Q3
$1.28K Sell
51
-925
-95% -$76.1K ﹤0.01% 3653
2023
Q2
$136K Sell
976
-64
-6% -$8.21K ﹤0.01% 3103
2023
Q1
$94.7K Buy
1,040
+293
+39% +$39.8K ﹤0.01% 3351
2022
Q4
$102K Buy
747
+11
+1% +$3.72K ﹤0.01% 3316
2022
Q3
$638K Sell
736
-182
-20% -$114K ﹤0.01% 2247
2022
Q2
$402K Buy
918
+813
+774% +$424K ﹤0.01% 2742
2022
Q1
$67K Buy
105
+19
+22% +$12K ﹤0.01% 3739
2021
Q4
$77K Sell
86
-109
-56% -$115K ﹤0.01% 3814
2021
Q3
$247K Buy
+195
New +$236K ﹤0.01% 3456
2020
Q4
Sell
-6,976
Closed -$7.26M 4553
2020
Q3
$7.26M Buy
+6,976
New +$7.29M 0.01% 1097

Other funds holding CANO

Deutsche Bank's CANO Position: Q1 2024 in Review

Deutsche Bank sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 51 shares — an estimated $299 sold.

Deutsche Bank first reported a position in CANO in Q3 2020 and held it in 11 quarters. The position peaked at $7.26M in Q3 2020. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Deutsche Bank reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 51 Cano Health, Inc. shares in Q1 2024, an estimated $299.
  • Deutsche Bank first reported a position in Cano Health, Inc. in Q3 2020 and held it in 11 quarters.
  • Deutsche Bank's Cano Health, Inc. position peaked at $7.26M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.